Stay updated on Venetoclax/Azacitidine Maintenance in AML Clinical Trial

Sign up to get notified when there's something new on the Venetoclax/Azacitidine Maintenance in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax/Azacitidine Maintenance in AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    An NIH notice announces a transition in terminology, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.
    Difference
    0.3%
    Check dated 2026-10-21T21:51:13.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-14T22:00:47.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-07T22:10:09.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.7.0' was added to the record history, signaling a platform update. The prior 'Revision: v3.6.6' entry was removed from the history.
    Difference
    0.0%
    Check dated 2026-09-16T21:45:25.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The history now shows a new revision entry updating the page from v3.6.5 to v3.6.6. This represents a small platform update to the record history page.
    Difference
    0.0%
    Check dated 2026-09-02T19:32:47.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The history now records a new page revision, updating the version from v3.6.4 to v3.6.5.
    Difference
    0.0%
    Check dated 2026-08-12T02:16:35.000Z thumbnail image

Stay in the know with updates to Venetoclax/Azacitidine Maintenance in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax/Azacitidine Maintenance in AML Clinical Trial page.